Foster Dykema Cabot & Co. Inc. MA Purchases Shares of 340 Waters Co. (NYSE:WAT)
Foster Dykema Cabot & Co. Inc. MA Purchases Shares of 340 Waters Co. (NYSE:WAT)
Foster Dykema Cabot & Co. Inc. MA purchased a new stake in Waters Co. (NYSE:WAT – Get Rating) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 340 shares of the medical instruments supplier's stock, valued at approximately $113,000.
根据Waters Co.最近提交给美国证券交易委员会的13F文件，福斯特·Dykema Cabot&Co.Inc.Ma在第二季度购买了Waters Co.(纽约证券交易所代码：WAT-GET Rating)的新股份。该机构投资者购买了这家医疗器械供应商的340股股票，价值约11.3万美元。
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Ellevest Inc. boosted its stake in shares of Waters by 144.4% in the 1st quarter. Ellevest Inc. now owns 88 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 52 shares during the last quarter. Kenfarb & CO. bought a new stake in shares of Waters in the 4th quarter valued at $48,000. Tyler Stone Wealth Management bought a new stake in shares of Waters in the 4th quarter valued at $56,000. Allworth Financial LP boosted its stake in shares of Waters by 48.4% in the 2nd quarter. Allworth Financial LP now owns 187 shares of the medical instruments supplier's stock valued at $62,000 after purchasing an additional 61 shares during the last quarter. Finally, Quent Capital LLC bought a new stake in shares of Waters in the 4th quarter valued at $75,000. 88.80% of the stock is currently owned by institutional investors and hedge funds.
其他几家机构投资者和对冲基金最近也增持或减持了该业务的股份。Ellevest Inc.在第一季度增持了144.4%的Waters股票。Ellevest Inc.现在持有这家医疗器械供应商88股股票，价值2.7万美元，该公司在上个季度又购买了52股。肯法布公司在第四季度购买了Waters的新股份，价值4.8万美元。泰勒·斯通财富管理公司(Tyler Stone Wealth Management)在第四季度购买了Waters价值5.6万美元的新股。Allworth Financial LP在第二季度增持了48.4%的Waters股票。Allworth Financial LP在上个季度额外购买了61股后，现在拥有187股这家医疗器械供应商的股票，价值6.2万美元。最后，Quent Capital LLC在第四季度购买了Waters的新股份，价值7.5万美元。88.80%的股票目前由机构投资者和对冲基金持有。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of equities research analysts have recently commented on WAT shares. Barclays reduced their price objective on shares of Waters from $375.00 to $345.00 and set an "overweight" rating on the stock in a research note on Monday, September 12th. Cowen increased their target price on shares of Waters to $378.00 in a research note on Tuesday, August 9th. Credit Suisse Group initiated coverage on shares of Waters in a research note on Wednesday, August 24th. They set a "neutral" rating and a $345.00 target price on the stock. Robert W. Baird increased their target price on shares of Waters from $340.00 to $348.00 in a research note on Wednesday, August 3rd. Finally, UBS Group increased their target price on shares of Waters from $349.00 to $375.00 and gave the stock a "neutral" rating in a research note on Thursday, August 4th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $348.25.
一些股票研究分析师最近对Wat股票发表了评论。巴克莱将Waters股票的目标价从375.00美元下调至345.00美元，并在9月12日星期一的一份研究报告中对该股设定了“增持”评级。考恩在8月9日周二的一份研究报告中将Waters的目标价上调至378.00美元。瑞士信贷集团在8月24日星期三的一份研究报告中启动了对Waters股票的报道。他们为该股设定了“中性”评级和345.00美元的目标价。罗伯特·W·贝尔德在8月3日星期三的一份研究报告中将Waters的目标股价从340.00美元上调至348.00美元。最后，瑞银集团将Waters股票的目标价从349.00美元上调至375.00美元，并在8月4日(星期四)的一份研究报告中给出了该股“中性”的评级。五名投资分析师对该股的评级为持有，两名分析师对该股的评级为买入。根据MarketBeat.com的数据，该股目前的共识评级为持有，共识目标价为348.25美元。
Waters Stock Up 0.1 %
Waters股价上涨0.1%
Waters (NYSE:WAT – Get Rating) last released its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. Waters had a net margin of 24.21% and a return on equity of 203.31%. The firm had revenue of $714.30 million for the quarter, compared to analyst estimates of $706.77 million. During the same period last year, the firm earned $2.60 earnings per share. The business's quarterly revenue was up 4.8% compared to the same quarter last year. On average, research analysts forecast that Waters Co. will post 12 earnings per share for the current year.
Waters(NYSE：WAT-GET评级)最近一次发布季度收益数据是在8月2日星期二。这家医疗器械供应商公布本季度每股收益为2.75美元，比分析师普遍预期的2.63美元高出0.12美元。Waters的净利润率为24.21%，股本回报率为203.31%。该公司本季度营收为7.143亿美元，而分析师预期为7.0677亿美元。去年同期，该公司每股收益为2.60美元。与去年同期相比，该业务的季度收入增长了4.8%。研究分析师平均预测，Waters Co.本年度每股收益将达到12欧元。
About Waters
关于沃特斯
(Get Rating)
(获取评级)
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Waters Corporation是一家专业测量公司，在亚洲、美洲和欧洲提供分析工作流程解决方案。它通过两个部门运营，Waters和TA。该公司设计、制造、销售和服务高性能和超高性能液相色谱，以及质谱仪(MS)技术系统和支持产品，包括色谱柱、其他消耗品和保修后服务计划。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Waters (WAT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 免费获取StockNews.com关于Waters的研究报告(Wat)
- 华尔街对Datadog的热情会带来巨大的收益吗？
- MarketBeat：回顾一周9/19-9/23
- 为什么特斯拉的股票保持弹性？
- 好市多盈利后价格疲软是买入的好时机吗？
- 小盘股的裁员是楼市的晴雨表吗？
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Waters Daily》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Waters和相关公司的最新新闻和分析师评级的每日简要摘要。